Product Description
| Brand | Snibe |
| Sample Type | Serum |
| Pack Size | 100T |
| CAT No. | 130269017M |
| Application | Covid |
The kit has been designed for the quantitative determination of IgG antibodies against the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein in human serum or plasma. The method can be used for samples within a measuring range of 0.1100 AU/mL. The test is performed on fully automated MAGLUMI chemiluminescence immunoassay (CLIA) analyzers, including MAGLUMI 800, MAGLUMI X8, and other MAGLUMI models such as MAGLUMI 1000, MAGLUMI 2000, MAGLUMI 2000 Plus, and MAGLUMI 4000.Reliable Detection with MAGLUMI CLIA TechnologyUtilizing chemiluminescence immunoassay (CLIA) technology, the MAGLUMI SARS-CoV-2 S-RBD IgG reagent kit ensures sensitive and specific detection of IgG antibodies related to SARS-CoV-2. The kit is engineered for use with MAGLUMI analyzers, providing robust and reproducible results suitable for clinical decision-making.
Optimized Storage for Consistent PerformanceTo maintain the integrity of the reagents, store the MAGLUMI SARS-CoV-2 S-RBD IgG kit at temperatures between 2C and 8C. Proper storage helps ensure accuracy and prolonged shelf life, making the kit reliable for ongoing laboratory operations.
FAQ's of Snibe MAGLUMI SARS-CoV-2 S-RBD IgG (CLIA):
Q: How do I use the Snibe MAGLUMI SARS-CoV-2 S-RBD IgG (CLIA) kit in my laboratory?
A: This kit is specifically designed for use with MAGLUMI CLIA analyzers. Follow the manufacturer's protocol provided in the kit for reagent preparation and measurement, ensuring all steps align with your analyzer's operational guidelines.
Q: What technology does this reagent kit employ for antibody detection?
A: The kit utilizes chemiluminescence immunoassay (CLIA) technology, which offers enhanced sensitivity for detecting IgG antibodies against the SARS-CoV-2 spike RBD.
Q: Where should I store the Snibe MAGLUMI SARS-CoV-2 S-RBD IgG reagents to maintain effectiveness?
A: Store all reagents between 2C and 8C as recommended. Keeping the kit within this temperature range preserves reagent stability and ensures consistent assay results.
Q: When is this kit suitable for use in clinical or research settings?
A: The reagent kit is ideal for routine laboratory use, including real-time analysis for SARS-CoV-2 antibody detection during epidemiological studies or patient diagnostics.
Q: What are the benefits of choosing the MAGLUMI S-RBD IgG (CLIA) kit?
A: This kit offers high sensitivity and specificity, supports real-time laboratory operations, and integrates seamlessly with MAGLUMI analyzers, promoting efficiency in clinical and research workflows.
Q: Who can purchase these reagents in India?
A: The product is available across India through authorized dealers, distributors, manufacturers, suppliers, traders, and wholesalers, meeting the needs of diverse laboratory settings.